Abstract
We investigate the relationship between bias about the severity of infectious disease and social well-being.
First, we establish empirically the existence of bias and some of its causes; specifically, during the COVID-19 pandemic.
Second, we derive an integrated economic-epidemiological differential equation model from an agent-based model that combines myopic rational choice with infectious disease dynamics. Third, we characterize axiomatically a model of an ethical, impartial, eudaemonistic and individualist observer. We proof that such an observer evaluates the state of society (social welfare or well-being) according to the utilitarian principle.
Fourth, we show numerically, that while increased risk-perception indeed improves epidemiological outcomes such as peak of infections and total incidence, the impact on social well-being is ambiguous. This result urges to look beyond cases and deaths.
Finally, we point out three possible future research directions and highlight some critical issues that arise in the normative direction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research has been conducted as part of the Covid & AI project, which is funded by Ministry of Science and Health of Rhineland-Palatinate, Germany.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
* Major revision of introduction, discussion and conclusion sections. * Higher quality figures. * Other textual changes are marked in blue.
